期刊文献+

Induced pluripotent stem cells(iPSCs)——a new era of reprogramming 被引量:5

Induced pluripotent stem cells(iPSCs)——a new era of reprogramming
原文传递
导出
摘要 Embryonic stem cells (ESCs) derived from the early embryos possess two important characteristics:self-renewal and pluripotency,which make ESCs ideal seed cells that could be potentially utilized for curing a number of degenerative and genetic diseases clinically.However,ethical concerns and immune rejection after cell transplantation limited the clinical application of ESCs.Fortunately,the recent advances in induced pluripotent stem cell (iPSC) research have clearly shown that differentiated somatic cells from various species could be reprogrammed into pluripotent state by ectopically expressing a combination of several transcription factors,which are highly enriched in ESCs.This ground-breaking achievement could circumvent most of the limitations that ESCs faced.However,it remains challenging if the iPS cell lines,especially the human iPSCs lines,available are fully pluripotent.Therefore,it is prerequisite to establish a molecular standard to distinguish the better quality iPSCs from the inferior ones. Embryonic stem cells (ESCs) derived from the early embryos possess two important characteristics:self-renewal and pluripotency,which make ESCs ideal seed cells that could be potentially utilized for curing a number of degenerative and genetic diseases clinically.However,ethical concerns and immune rejection after cell transplantation limited the clinical application of ESCs.Fortunately,the recent advances in induced pluripotent stem cell (iPSC) research have clearly shown that differentiated somatic cells from various species could be reprogrammed into pluripotent state by ectopically expressing a combination of several transcription factors,which are highly enriched in ESCs.This ground-breaking achievement could circumvent most of the limitations that ESCs faced.However,it remains challenging if the iPS cell lines,especially the human iPSCs lines,available are fully pluripotent.Therefore,it is prerequisite to establish a molecular standard to distinguish the better quality iPSCs from the inferior ones.
出处 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2010年第7期415-421,共7页 遗传学报(英文版)
基金 supported by the grants from the Ministry of Science and Technology of China (Nos 2008AA022311,2010CB944900 and 2008AA1011005)
关键词 induced pluripotent stem cells (iPSCs) REPROGRAMMING molecular events induced pluripotent stem cells (iPSCs) reprogramming molecular events
  • 相关文献

参考文献1

二级参考文献1

共引文献61

同被引文献19

  • 1Essam M. Abdelalim,Amélie Bonnefond,Annelise Bennaceur-Griscelli,Philippe Froguel.Pluripotent Stem Cells as a Potential Tool for Disease Modelling and Cell Therapy in Diabetes[J].Stem Cell Reviews and Reports.2014(3)
  • 2Walid Hamdy El-Tantawy,Ekram Nemr Abd Al Haleem.Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats[J].Molecular and Cellular Biochemistry (-).2014(1-2)
  • 3Sara D. Qi,Paul D. Smith,Peter F. Choong.Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons[J].ANZ J Surg.2014(6)
  • 4Maria Sambataro,Elena Seganfreddo,Fabio Canal,Anna Furlan,Laura del Pup,Monia Niero,Agostino Paccagnella,Filippo Gherlinzoni,Angelo Paolo dei Tos,Georgios Vourliotakis.Prognostic Significance of Circulating and Endothelial Progenitor Cell Markers in Type 2 Diabetic Foot[J].International Journal of Vascular Medicine.2014
  • 5Francesco Paneni,Joshua A. Beckman,Mark A. Creager,Francesco Cosentino.Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I[J].European Heart Journal.2013(31)
  • 6Z. Tancos,C. Nemes,Z. Polgar,E. Gocza,N. Daniel,T.A.E. Stout,P. Maraghechi,M.K. Pirity,P. Osteil,Y. Tapponnier,S. Markossian,M. Godet,M. Afanassieff,Z. Bosze,V. Duranthon,P. Savatier,A. Dinnyes.Generation of rabbit pluripotent stem cell lines[J].Theriogenology.2012(8)
  • 7Young-Doug Sohn,Ji Woong Han,Young-sup Yoon.Generation of Induced Pluripotent Stem Cells from Somatic Cells[J].Progress in Molecular Biology and Translational Science.2012
  • 8Insa Schroeder.Potential of Pluripotent Stem Cells for Diabetes Therapy[J].Current Diabetes Reports.2012(5)
  • 9O. Naujok,S. Lenzen.Pluripotente Stammzellen zur Zellersatztherapiedes Diabetes mellitus[J].Dtsch med Wochenschr.2012(20)
  • 10Ori Bar-Nur,Holger A. Russ,Shimon Efrat,Nissim Benvenisty.Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells[J].Cell Stem Cell.2011(1)

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部